VALERIE CARNES: Open Payments
NPI 1992108716 · LA JUNTA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 10 payments from 8 companies in 2025. Trend: 2023 $103 · 2024 $240 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| Viatris Specialty LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Verona Pharma, Inc. | 1 | $15 |
Products named: VRAYLAR, YUPELRI, Rybelsus, Cologuard Collection Kit, AUSTEDO XR, Ozempic, OTEZLA, GVOKE HYPOPEN.
Industry payments across CO — which companies pay providers there.
